From August 12 to 13, the 2026 PCHi Personal Care and Cosmetics Industry Leadership Summit and Innovative Technology Exhibition was held in Guangzhou.

Guangdong Qingyunshan Traditional Chinese Medicine Innovation Research and Development Co., Ltd., a subsidiary of  Tech-inno, made a high-profile appearance with two new cosmetic ingredients: ‌MitoYouth® Urolithin A‌ and ‌SenoFis™ Fisetin‌. At the summit's thematic forum on "Skin Mechanisms and Medical-Research Co-Creation," Dr. Yang Ke, Scientific Director of  Tech-inno, was invited to deliver a keynote presentation on ‌"Cellular Homeostasis Solutions for Stressed Skin,"‌ bringing the industry new perspectives on cellular "anti-aging + repair" based on the new paradigm of aging.

‌Key Presentation‌: Cellular Homeostasis Solutions for Stressed Skin — Applications of Urolithin A and Fisetin in Anti-Aging and Repair

As consumer demand for "premature aging prevention" and "barrier repair" continues to rise, "stressed skin" has become a focal topic in the industry. The core issue of "stressed skin" is not simply a matter of skin type, but rather ‌the loss of skin homeostasis and resilience‌. Skin aging is the most fundamental driver of stressed skin, the essence of which lies in the imbalance of the cellular homeostasis network. When internal and external stressors chronically exceed the skin's recovery capacity, the skin enters the aging-related "stressed skin" state.

Using the "cellular homeostasis network" as its theoretical framework,  Tech-inno systematically deconstructs skin aging mechanisms and the new concept of healthy aging across four dimensions: ‌the information layer, foundational layer, execution layer, and systemic layer‌. The company prominently showcased its dual-pillar ingredient combination of ‌MitoYouth® Urolithin A‌ and ‌SenoFis™ Fisetin‌ for "anti-aging + repair," establishing a complete evidence chain from cellular mechanisms to human efficacy, and providing a full-pathway solution for stressed skin intervention.

Enthusiastic exchanges continue at the booth regarding MitoYouth® Urolithin A and SenoFis™ Fisetin products.‌

‌Engaging the Industry with Science, Empowering Products with Innovation‌

As the 2026 PCHi Leadership Summit successfully concluded,  Tech-inno's dual-pillar combination strategy featuring MitoYouth® Urolithin A and SenoFis™ Fisetin is demonstrating its full-chain capabilities through ‌"scientific evidence-based research + efficacy validation,"‌ presenting upstream and downstream industry partners with an innovative skin longevity solution that transitions from "describing aging" to "designing aging."